Error in article information (JAMA Internal Medicine (2014) 174, 2 (281-285) DOI: 10.1001/jamainternmed.2013.12745);The harms of screening : A proposed taxonomy and application to lung cancer screening

JAMA Internal Medicine

Volumn 174, Issue 2, 2014, Pages 281-285

  Harris, Russell P ^a,b   Sheridan, Stacey L ^a,b   Lewis, Carmen L ^a,b   Barclay, Colleen ^a   Vu, Maihan B ^a,c   Kistler, Christine E ^a,b   Golin, Carol E ^a,b,c   DeFrank, Jessica T ^a,c   Brewer, Noel T ^a,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER PATIENT; CANCER RESEARCH; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; IMAGE ANALYSIS; LUNG CANCER; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL LITERATURE; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SYSTEMATIC REVIEW; TAXONOMY;

DECISION MAKING; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MORBIDITY; WORLD HEALTH;

EID: 84893534434     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.113     Document Type: Erratum

References (38)

1. Harris R, Sawaya GF,Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the US Preventive Services Task Force. Epidemiol Rev. 2011;33(1):20-35.
2. US Preventive Services Task Force. Procedure Manual. July 2008. AHRQ Publication No. 08-05118-EF. http://www.uspreventiveservicestaskforce. org/uspstf08/methods/procmanual.htm. Accessed June 10, 2013.
3. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D; US Preventive Services Task Force. Update on themethods of the US Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007;147(12):871-875.
4. Woolf SH, Harris R. The harms of screening: new attention to an old concern. JAMA. 2012;307(6):565-566.
5. Chou R, Helfand M. Challenges in systematic reviews that assess treatment harms. Ann Intern Med. 2005;142(12, pt 2):1090-1099.
6. Choosing Wisely: an Initiative of the ABIM Foundation. http://www.choosingwisely.org. Accessed June 10, 2013.
7. Schwartz LM,Woloshin S, Fowler FJ Jr.,Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78.
8. Sirovich BE,Woloshin S, Schwartz LM. Too little? too much? primary care physicians' views on US health care: a brief report. Arch Intern Med. 2011;171(17):1582-1585.
9. Hoffman RM, Lewis CL, Pignone MP, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30(5)(suppl): 53S-64S.
10. US Preventive Services Task Force. Recommendations. http://www. uspreventiveservicestaskforce. org/recommendations.htm. Accessed June 10, 2013.
11. Humphrey L, Deffebach M, Pappas M, et al. Screening for Lung Cancer: Systematic Review to Update the US Preventive Services Task Force Recommendation: Evidence Synthesis No. 105. Rockville, MD: Agency for Healthcare Research and Quality; 2013. AHRQ Publication No. 13-05188-EF-1.
12. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-2429.
13. Smith-Bindman R. Is computed tomography safe? N Engl J Med. 2010;363(1):1-4.
14. US Preventive Services Task Force. Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: draft recommendation statement. AHRQ Publication No. 13-05196-EF-3. http://www.uspreventiveservicestaskforce.org/draftrec.htm. Accessed August 26, 2013.
15. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
16. Wiener RS, Schwartz LM,Woloshin S,Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med. 2011;155(3):137-144.
17. Veronesi G, Maisonneuve P, Bellomi M, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2012;157(11):776-784.
18. Kubík AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000;89(11)(suppl):2363-2368.
19. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92(16):1308-1316.
20. Aggestrup LM, Hestbech MS, Siersma V, Pedersen JH, Brodersen J. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open. 2012;2(2):e000663.
21. Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health. 2010;13(5):601-612.
22. Byrne MM,Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making. 2008;28(6):917-925.
23. Kaerlev L, Iachina M, Pedersen JH, Green A, Nørgård BM. CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer. 2012;12(1):188.
24. McGovern PM, Gross CR, Krueger RA, Engelhard DA, Cordes JE, Church TR. False-positive cancer screens and health-related quality of life. Cancer Nurs. 2004;27(5):347-352.
25. Nekolaichuk CL, Cumming C, Turner J, Yushchyshyn A, Sela R. Referral patterns and psychosocial distress in cancer patients accessing a psycho-oncology counseling service. Psychooncology. 2011;20(3):326-332.
26. Reeve BB, Potosky AL, Smith AW, et al. Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst. 2009;101(12): 860-868.
27. Sinicrope PS, Rabe KG, Brockman TA, et al. Perceptions of lung cancer risk and beliefs in screening accuracy of spiral computed tomography among high-risk lung cancer family members. Acad Radiol. 2010;17(8):1012-1025.
28. Steinberg T, Roseman M, Kasymjanova G, et al. Prevalence of emotional distress in newly diagnosed lung cancer patients. Support Care Cancer. 2009;17(12):1493-1497.
29. van den Bergh KA, Essink-Bot ML, Bunge EM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer. 2008;113(2):396-404.
30. van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer. 2010;102(1):27-34.
31. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J. 2011;38(1):154-161.
32. Vierikko T, Kivistö S, Järvenpää R, et al. Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers. Eur J Cancer Prev. 2009;18(3):203-206.
33. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5)(suppl): e78S-e92S.
34. Bunge EM, van den Bergh KA, Essink-Bot ML, van Klaveren RJ, de Koning HJ. High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer. Lung Cancer. 2008;62(3):385-390.
35. Marlow LA,Waller J,Wardle J. Variation in blame attributions across different cancer types. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1799-1805.
36. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19-28.
37. Church TR, BlackWC, Aberle DR, et al; National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368(21):1980-1991.
38. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology. 2010;19(10):1026-1034.